Element Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-115,050
Closed -$6.07M 38
2023
Q3
$6.07M Sell
115,050
-68,517
-37% -$3.59M 0.54% 50
2023
Q2
$9.93M Buy
183,567
+9,822
+6% +$513K 0.67% 38
2023
Q1
$8.69M Buy
+173,745
New +$8.19M 0.66% 47
2019
Q3
Sell
-37,188
Closed -$1.6M 238
2019
Q2
$1.6M Buy
+37,188
New +$1.43M 0.11% 176
2019
Q1
Sell
-14,503
Closed -$513K 831
2018
Q4
$513K Sell
14,503
-6,150
-30% -$223K 0.01% 358
2018
Q3
$795K Buy
20,653
+13,815
+202% +$483K 0.02% 374
2018
Q2
$224K Buy
+6,838
New +$206K 0.01% 675
2015
Q3
Sell
-1,300
Closed -$23K 137
2015
Q2
$23K Buy
+1,300
New +$23.2K 0.01% 263

Other funds holding BSX

Element Capital Management's BSX Position: Q4 2023 in Review

Element Capital Management sold out of Boston Scientific (BSX) in Q4 2023, closing a stake of 115,050 shares — an estimated $6.07M sold.

Element Capital Management first reported a position in BSX in Q2 2015 and held it in 8 quarters. The position peaked at $9.93M in Q2 2023. 1,150 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

  • Element Capital Management reported no remaining Boston Scientific position as of Q4 2023 after selling out during the quarter.
  • Element Capital Management sold 115,050 Boston Scientific shares in Q4 2023, an estimated $6.07M.
  • Element Capital Management first reported a position in Boston Scientific in Q2 2015 and held it in 8 quarters.
  • Element Capital Management's Boston Scientific position peaked at $9.93M in Q2 2023.
  • 1,150 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Element Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.